just as the paint dries...
or should I say ink dries...
interesting reading in the TAG HIV Pipeline report...
in the section describing "some of the most pressing priorities" for the HIV market
"Despite the unprecedented progress in both research and access over the past decade, many unmet medical and public-health needs remain for future HIV treatments and programs.
A cheap, daily (or less often) FDC that is super-potent, safe, tolerable, nontoxic, and with a high barrier to resistance
New backbone drugs. Novel nucleoside backbones
which do not use tenofovir or AZT could be helpful, both for toxicity reduction and for greater strategic options in second-line therapy and beyond."
less often than daily not a problem?
non-toxic, options for 2nd-line and beyond?
Any ideas...?
I think ATC will fit the bill, nicely...
phaps ol' Drongo should have a read...
but then he probably still prefers ddC, lol
http://www.treatmentactiongroup.org/uploadedFiles/About/Publications/TAG_Publications/TAG_Pipeline/TAGPipeline2011.pdf
Add to My Watchlist
What is My Watchlist?